Daniel Wendling is an expert in Rheumatology at Centre Hospitalier Universitaire de Besançon (France). As of October 2026, ScienceLeadR ranks Daniel Wendling in the top 1% of experts worldwide for Ankylosis, Axial Spondyloarthritis and Spondylarthritis. Daniel Wendling has authored 1,134 publications, the most recent in 2026, and is an investigator in 21 clinical trials, 3 of them ongoing. SLR score: 3,483 (community average: 125). How the SLR is computed.

LeadR Profile

3 483 ScienceLeadR Reputation 3483
Network Map

Rheumatology

Subspecialties: Pharmacy - Cardiology - Dermatology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1988 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Besançon

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 1134

Citations

Citations: 18 724 1st author: 285 Last author: 291 Unique author: 57


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Psoriatic arthritis phase 3 trials: larger effects, but for whom?
PMID 42448216 — arthritis, psoriatic, joint diseases, arthritis
Joint Bone Spine20260
Spondyloarthritis and inflammatory bowel disease: towards a more severe and refractory disease phenotype.
PMID 42370112 — phenotype, inflammatory bowel diseases, diagnosis, therapeutics, psoriasis, smoking, uveitis
EULAR Rheumatol Open20261
Diagnostic accuracy of 18F-FDG PET-CT scores in distinguishing polymyalgia rheumatica from other inflammatory rheumatic diseases: a multicentre retrospective study (RHUMATEP).
PMID 42337036 — retrospective studies, positron emission tomography computed tomography, algorithms, rheumatic diseases, fluorodeoxyglucose f18, nuclear medicine, polymyalgia rheumatica
Eur J Nucl Med Mol Imaging20260
Discrepancies in the assessment of axial spondyloarthritis between patients and rheumatologists: what does this mean?
PMID 42176069 — rheumatologists, axial spondyloarthritis
Clin Rheumatol20260
Late-onset psoriatic arthritis: a separate entity.
PMID 42031138 — arthritis, psoriatic, comorbidity, arthritis, therapeutics
Joint Bone Spine20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 14
Phase 4 4
Phase 3 3

By status:

Completed 17
Recruiting 2
Not yet recruiting 1
Unknown 1

By type:

Interventional 17
Observational 4

By Monocentric/Multicentric:

monocentric 10
multicentric2to4 3
multicentric5to9 0
multicentricup10 8

Main Topics

Cohort/Consortium Investigators 4

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Initial Standardized Global Review in Axial Spondyloarthritis
NCT07141017 — rheumatology, comorbidity, general practitioners, treatment adherence and compliance, rheumatologists, pharmacists, phenotype, spondylarthritis, diagnosis, therapeutics, education, axial spondyloarthritis
N/ARecruiting2025
Justification of the Initial Diagnosis and Evaluation of the Overall Evolution of a Cohort of Recent Polymyalgia Rheumatica (JADORE)
NCT07132164 — diagnosis, differential, research design, marketing, blood, prednisone, rheumatic fever, adrenal cortex hormones, arthritis, pathology, rheumatic diseases, aged, specimen handling, arthritis, rheumatoid, diagnosis, therapeutics, polymyalgia rheumatica, gastrointestinal microbiome, microbiota
N/ANot yet recruiting2026
Platelet rich Plasma in Symptomatic Knee Osteoarthritis
NCT05378815 — platelet-rich plasma, injections, osteoarthritis, knee, osteoarthritis, injections, intra-articular, therapeutics, blood platelets, plasma
N/ARecruiting2025

LeadR Networks

Main global connection map